Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
4 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
16 authors at 7 institutions in 2 countries.
Nuno LopesInstituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, 4200-135 Porto, Portugal.
Maria L MaiaInstituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, 4200-135 Porto, Portugal.ORCID 0000-0003-4383-3822
Cátia S PereiraInstituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, 4200-135 Porto, Portugal.
Inês Mondragão-RodriguesInstituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-1425-1498
Esmeralda MartinsCentro de Referência de Doenças Hereditárias do Metabolismo (DHM), Centro Hospitalar Universitário de Santo António, 4099-001 Porto, Portugal.
Rosa RibeiroCentro de Referência de Doenças Hereditárias do Metabolismo (DHM), Centro Hospitalar Universitário de Santo António, 4099-001 Porto, Portugal.
Ana GasparCentro de Referência de Doenças Hereditárias do Metabolismo (DHM), Centro Hospitalar e Universitário Lisboa Norte (CHULN), 1649-035 Lisbon, Portugal.ORCID 0000-0003-3979-9924
Patrício AguiarCentro de Referência de Doenças Hereditárias do Metabolismo (DHM), Centro Hospitalar e Universitário Lisboa Norte (CHULN), 1649-035 Lisbon, Portugal.ORCID 0000-0003-2393-3463
Paula GarciaCentro de Referência de Doenças Hereditárias do Metabolismo (DHM), Centro Hospitalar e Universitário de Coimbra, Centro de Desenvolvimento da Criança, 3000-075 Coimbra, Portugal.ORCID 0000-0002-6847-745X
Maria Teresa CardosoCentro de Referência de Doenças Hereditárias do Metabolismo (DHM), Centro Hospitalar Universitário de São João (CHUSJ), 4200-319 Porto, Portugal.ORCID 0000-0001-9908-3739
Esmeralda RodriguesCentro de Referência de Doenças Hereditárias do Metabolismo (DHM), Centro Hospitalar Universitário de São João (CHUSJ), 4200-319 Porto, Portugal.ORCID 0000-0003-1864-1503
Elisa Leão-TelesCentro de Referência de Doenças Hereditárias do Metabolismo (DHM), Centro Hospitalar Universitário de São João (CHUSJ), 4200-319 Porto, Portugal.
Roberto GiuglianiHospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, DASA e Casa dos Raros, Porto Alegre 90610-150, Brazil.ORCID 0000-0001-9655-3686
Maria F CoutinhoResearch and Development Unit, Department of Genetics, INSA, 4000-055 Porto, Portugal.ORCID 0000-0002-2222-3622
Sandra AlvesResearch and Development Unit, Department of Genetics, INSA, 4000-055 Porto, Portugal.ORCID 0000-0002-8881-9197
M Fátima MacedoInstituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-2252-6105
Universidade do Porto · PTHospital de São João · PTHospital de Santo António · PTCentro Hospitalar Lisboa Norte · PTHospitais da Universidade de Coimbra · PTUniversidade Federal do Rio Grande do Sul · BRUniversity of Lisbon · PT
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Mucopolysaccharidoses (MPSs) are rare inherited lysosomal storage diseases (LSDs) caused by deficient activity in one of the enzymes responsible for glycosaminoglycans lysosomal degradation. MPS II is caused by pathogenic mutations in the
Indexed as
glycosaminoglycansinvariant natural killer T (iNKT) cellsleukocyteslysosomal storage diseasesmucopolysaccharidosesT cells
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Leukocyte Imbalances in Mucopolysaccharidoses Patients. · full record | OpenQuestion